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Background
DNA microarrays have been widely applied in cancer
research for better diagnosis and prediction of the dis-
ease states. Traditionally, most microarray studies aim
to identify differentially expressed genes (DEGs) by
comparing the average gene expression levels between
two groups (e.g., the treated vs. control or disease vs.
non-disease) based on statistical analysis such as t-test
and Significance Analysis of Microarrays (SAM) [1,2].
Materials and methods
In this study, we defined the gene expression profile
(GEP) of a gene as the distribution of the log2 values
of its normalized expression signal intensities across
the samples in the similarly studied microarrays. We
hypothesized that the biomarker genes that distinguish
disease samples from normal samples might form dis-
tinct GEPs between comparison groups. We applied
Pearson Correlation Coefficient (PCC) and Kolmo-
gorov-Smirnov Distance (KSD) metrics to identify dis-
ease-specific biomarkers by comparing GEPs between
normal and disease states and then applied this tech-
nology to disease (e.g., cancer) related studies in order
to discover some disease genes as biomarker candi-
dates. These biomarkers’ gene profiles in normal and
disease samples might be used to diagnose or monitor
patient ’s disease state via regular gene expression
analysis.
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Table 1 Top 10 gene pairs for top prediction accuracies
on PCA diagnosis.
Down gene Up gene True positive True negative Accuracy
PCC sort*
ACTA1 CRISP3 67/90 73/81 140/171
TGFB3 BICD1 72/90 68/81 140/171
ACTA1 HPN 76/90 63/81 139/171
MYL9 CRISP3 64/90 75/81 139/171
AL044599 BICD1 75/90 64/81 139/171
DMN CRISP3 65/90 73/81 138/171
GJA1 CRISP3 70/90 68/81 138/171
AL036744 CRISP3 65/90 73/81 138/171
DMN BICD1 69/90 69/81 138/171
ADH5 BICD1 71/90 67/81 138/171
KSD sort**
GSTP1 CRISP3 68/90 72/81 140/171
AOC3 CRISP3 69/90 70/81 139/171
GSTP1 UBE2C 66/90 73/81 139/171
HLA-E RGS10 71/90 68/81 139/171
GSTP1 HPN 70/90 68/81 138/171
DMN CRISP3 65/90 73/81 138/171
GJA1 CRISP3 70/90 68/81 138/171
HLA-E UBE2C 61/90 77/81 138/171
DMN BICD1 69/90 69/81 138/171
PALLD BICD1 66/90 72/81 138/171
*PCC sort: significant genes were separated into down- and up- regulated
groups, then the top 20 genes (sorted by Pearson Correlation Coefficient in
the cancer vs. normal GEPs for each gene) in each group were selected to
generate pair-wise gene-pairs for the PCA prediction.
**KSD sort: significant genes were separated into down- and up- regulated
groups, then the top 20 genes (sorted by Kolmogorov-Smirnov Distance in
the cancer vs. normal GEPs for each gene) in each group were selected to
generate pair-wise gene-pairs for the PCA prediction.
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Results and conclusion
We applied the PCC and KSD metrics to three prostate
cancer related microarray datasets. They were generated
from the same study and were available in the GEO
database (a total of 81 normal samples and 90 prostate
cancer samples) [3]. Using the cutoff values KSD > 0.4
and PCC < 0.7, we found 230 biomarker candidate
genes. Our Gene Ontology (GO) analysis found that the
top ranked biomarker candidate genes for prostate can-
cer were highly enriched in molecular functions such as
“cytoskeletal protein binding” category. We used the top
two ranked genes (ACTA1, encoding an actin subunit,
and HPN, encoding hepsin) to demonstrate that prostate
cancer might be diagnosed and monitored by marker
genes. Furthermore, we picked top 20 significantly up-
regulated and top 20 down-regulated genes based on
PCC and KSD sorting. We found gene pairs comprising
one up-regulated and another down-regulated had
always best prediction performance (Table 1). Our study
provided a promising tool to identify the potential bio-
marker genes for disease diagnosis and prognosis.
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